CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- 8-K Event Material agreement · Regulation FD disclosure
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · Regulation FD disclosure · Other events
- 4 Planned sale Chief Executive Officer sold 525,991 shares at $0.95 ($499,691)
- 144 Insider Sale of Securities
- 8-K Event Shareholder vote results
- 8-K Event Shareholder vote results
- 4 Planned sale Chief Executive Officer sold 525,991 shares at $1.12 ($589,110)
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure · Other events
- DEFA14A Proxy Proxy Materials
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
Page 1 of 45 · 895 filings